Philip H. Coelho - 24 Aug 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ Philip H. Coelho
Issuer symbol
CPRX
Transactions as of
24 Aug 2021
Net transactions value
-$1,780
Form type
4
Filing time
26 Aug 2021, 16:45:14 UTC
Previous filing
25 May 2021
Next filing
15 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $52,001 +16,667 +7.7% $3.12* 233,427 24 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $52,929 -9,494 -4.1% $5.58 223,933 24 Aug 2021 Direct F1
transaction CPRX Common stock, par value $0.001 per share Options Exercise $52,001 +16,667 +7.4% $3.12* 240,600 25 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $52,809 -9,498 -3.9% $5.56 231,102 25 Aug 2021 Direct F1
transaction CPRX Common stock, par value $0.001 per share Options Exercise $51,998 +16,666 +7.2% $3.12* 247,768 26 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $49,290 -9,044 -3.7% $5.45 238,724 26 Aug 2021 Direct F1
transaction CPRX Common stock, par value $0.001 per share Sale $2,752 -504 -0.21% $5.46 238,220 26 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -16,667 -4.7% $0.000000 339,500 24 Aug 2021 Common Stock 16,667 $3.12 Direct F2
transaction CPRX Options to purchase common stock Options Exercise $0 -16,667 -4.9% $0.000000 322,833 25 Aug 2021 Common Stock 16,667 $3.12 Direct F2
transaction CPRX Options to purchase common stock Options Exercise $0 -16,666 -5.2% $0.000000 306,167 26 Aug 2021 Common Stock 16,666 $3.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover exercise price of options.
F2 Options vested in two annual tranches beginning on August 28, 2014.